Showing results (1781-1790 of 1,850) with videos related to

Sort By:
Pageof 185
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2015
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy InitiationRupak Shivakoti, Wei-Teng Yang, Nikhil Gupte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantationKatherine N DuHamel, Catherine E Mosher, Gary Winkel, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 7, 2013
A molecular, isozyme and morphological map of the barley (Hordeum vulgare) genomeA Kleinhofs, A Kilian, M A Saghai Maroof, et al.
The Review of Scientific Instruments|October 31, 2021
Simplified feedback control system for scanning tunneling microscopyFrancisco Martín-Vega, Víctor Barrena, Raquel Sánchez-Barquilla, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor AntagonistMatthew Spock, Trever R Carter, Katrina A Bollinger, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
The Journal of Infectious Diseases|March 11, 2016
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected AdultsVidya Mave, Kristine M Erlandson, Nikhil Gupte, et al.
ACS Chemical Neuroscience|August 28, 2024
Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup CandidateJulie L Engers, Katrina A Bollinger, Rory A Capstick, et al.
Science Translational Medicine|June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's diseaseAura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Frontiers in Immunology|January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5Bin Yang, Guoqiang Fang, Isaac Marx, et al.
Pageof 185